MD2701G2 - Method of erysipelas treatment - Google Patents
Method of erysipelas treatmentInfo
- Publication number
- MD2701G2 MD2701G2 MDA20030264A MD20030264A MD2701G2 MD 2701 G2 MD2701 G2 MD 2701G2 MD A20030264 A MDA20030264 A MD A20030264A MD 20030264 A MD20030264 A MD 20030264A MD 2701 G2 MD2701 G2 MD 2701G2
- Authority
- MD
- Moldova
- Prior art keywords
- erysipelas
- treatment
- vitaminotherapy
- cytoprotective
- desensitizing
- Prior art date
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention refers to medicine, namely to the infectious diseases and may be applied in the erysipelas treatment.Summary of the invention consists in that there are administered antibacterial, desensitizing, diuretic preparations and it is carried out the vitaminotherapy. At the same time, additionally, in the capacity of local regenerative and cytoprotective preparation, there is used unrefined grapestone oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20030264A MD2701G2 (en) | 2003-11-06 | 2003-11-06 | Method of erysipelas treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20030264A MD2701G2 (en) | 2003-11-06 | 2003-11-06 | Method of erysipelas treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
MD2701F1 MD2701F1 (en) | 2005-02-28 |
MD2701G2 true MD2701G2 (en) | 2005-10-31 |
Family
ID=34374310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20030264A MD2701G2 (en) | 2003-11-06 | 2003-11-06 | Method of erysipelas treatment |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD2701G2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1140C2 (en) * | 1997-07-15 | 1999-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Remedy possessing a regenerative and cytoprotective activity |
MD2070G2 (en) * | 2002-07-12 | 2003-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Utilization of the unrefined grapestone oil in the treatment of gastric and duodenal ulcers |
MD2164G2 (en) * | 2002-10-22 | 2003-11-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of treatment of ocular contusions |
-
2003
- 2003-11-06 MD MDA20030264A patent/MD2701G2/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1140C2 (en) * | 1997-07-15 | 1999-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Remedy possessing a regenerative and cytoprotective activity |
MD2070G2 (en) * | 2002-07-12 | 2003-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Utilization of the unrefined grapestone oil in the treatment of gastric and duodenal ulcers |
MD2164G2 (en) * | 2002-10-22 | 2003-11-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of treatment of ocular contusions |
Non-Patent Citations (1)
Title |
---|
Standarde medico-financiare profil terapeutic adulţi. Ministerul Sănătăţii Republica Moldova. Centrul Ştiinţifico-practic Sănătate şi Management Sanitar. Aprobat prin Ordinul MS din 02.08.2002, nr. 207. Chişinău, 2002, p.227 * |
Also Published As
Publication number | Publication date |
---|---|
MD2701F1 (en) | 2005-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69929232D1 (en) | VIRUSELY PARTICLES FOR INDUCING AUTOANTIC BODIES | |
TW200507874A (en) | Immunostimulatory nucleic acid oil-in-water formulations and related methods of use | |
FI956014A (en) | Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS | |
WO2005055944A3 (en) | Oligosaccharide compositions and use thereof in the treatment of infection | |
HUP9901144A2 (en) | Pharmaceutical compositions containing new associations of clopidogrel and an antithrombotic agent | |
WO1999064059A3 (en) | Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders | |
IL175158A0 (en) | Tocopherol-modified therapeutic drug compounds | |
MXPA05002814A (en) | Formulation for lipophilic agents. | |
MX272108B (en) | Substituted heterocycles. | |
AU2002248384A1 (en) | Serpin drugs for treatment of hiv infection and method of use thereof | |
IL171974A0 (en) | Tetrahydrocarbazole derivatives and their pharmaceutical use | |
DE60033649D1 (en) | COMPOUNDS AND THERAPEUTIC METHODS | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
DE60320034D1 (en) | TREATMENT OF MASTITIS WITH A COMBINATION OF PREDNISOLONE AND CEPHALOSPORIN | |
WO2002067771A3 (en) | Chemokine receptors and disease | |
WO2004030631A3 (en) | Anti-cancer and anti-infectious disease compositions and methods for using same | |
WO1999056666A8 (en) | The treatment of sexual dysfunction in certain patient groups | |
WO2005002617A3 (en) | Use of compositions comprising a soluble form of hla-g in the treatment of blood diseases | |
AU2001267561A1 (en) | Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents | |
MD2701G2 (en) | Method of erysipelas treatment | |
ATE548048T1 (en) | ONCOMODULIN FOR THE TREATMENT OF NEUROLOGICAL DISEASES | |
EA200000909A1 (en) | FORM VI 5,6-DICHLOR-2- (ISOPROPYLAMINO) -1- (b-L-RIBOFURANOSIL) -1H-BENZIMIDAZOLE | |
WO2000078800A3 (en) | Combined decorin binding protein and outer surface protein compositions and methods of use | |
WO2002076930A3 (en) | Substituted diarylureas as stimulators for fas-mediated apoptosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |